obesity-995x60.png obesity-995x60.png

FEATURED ARTICLES

The Race In Diabetes R&D
The Race In Diabetes R&D

GSK and other drug discovery and development companies are taking new aim on the global diabetes explosion – sometimes alone, sometimes in league together.

More Featured Articles

WHITE PAPERS AND CASE STUDIES

  • The Environmental Impact of Clinical Trials

    For many years it has been almost universally accepted that there are various sources that may impact or cause disease among which biological, social, and environmental differences have all been investigated. Many clinical trials have been conducted to assess the impact of the environment on outcomes e.g., the effect of the environment on the outcome of studies assessing the efficacy of drugs for patients with dry-eye syndrome, the impact of diet on obesity and cardiovascular disease, and the impact of the environment on autoimmune diseases have all been studied, as have many other interactions.

  • Overcoming Clinical Challenges In Metabolic And Cardiovascular Disease With Metabolomics

    Metabolic diseases (e.g. obesity, type 2 diabetes, and hypertension) are a rapidly expanding health care concern. Although there is a high demand for novel therapies, the challenges are substantial as existing drugs typically fail due to lack of efficacy or safety, and clinical studies often extremely large and protracted. 

More White Papers & Case Studies

SERVICES AND PRODUCTS

Endocrinology And Metabolism Endocrinology And Metabolism
We recognize one of the most important pieces of your outsourcing puzzle is a CRO’s therapeutic expertise. Theorem Clinical Research features experience in a variety of different major areas.
Public Health And Government Services Public Health And Government Services
Navigating the complexities of clinical development for government and other subsidized programs requires a partner who has a combination of therapeutic expertise and experience in the public health sector.
Endocrinology Endocrinology
We can be your partner to mitigate the effects of longer timelines, additional costs, and higher risk in your clinical development program.
More Services & Products

NEWS

More News